Breast cancer survivors may worry about undergoing fertility treatment, since it can often involve a boost in estrogen Now, new research found no differences in breast cancer recurrence whether or not survivors got fertility treatments The genes in question are variants of BRCA1 and BRCA2 MONDAY, May 20, 2024 (HealthDay News) -- Fertility treatments such as in vitro fertilization (IVF) and other methods don't boost the odds for tumor recurrence in young women who've survived breast cancer and carry the BRCA cancer genes, a reassuring, new report finds. The issue had been in question because breast tissue can be sensitive to hormones and many assisted reproductive techniques (ARTs) involve a temporary boost in estrogen. However, the new Italian study "provides the first evidence" that procedures are safe in women with those variants of the BRCA1 and BRCA 2 genes that are known to raise risks for breast and ovarian cancers, said study lead author .
He spoke in a news release from the European Society for Medical Oncology (ESMO). Lambertini's team presented its findings last week at ESMO's annual meeting in Lugano, Switzerland. The new findings "provide reassuring evidence for these women and their doctors to consider when discussing the risks and benefits of using ART to preserve their chances of having a baby following completion of anti-cancer therapies,” said Lambertini, an associate professor of medical oncology at the University of Genova.
As the researchers explained, w.
